| NCT Number | NCT07662239 |
| Lead Sponsor | Dana-Farber Cancer Institute |
| Conditions | Sarcoma, Bone Sarcoma, Soft Tissue Sarcoma (STS) |
| Enrollment | 40 participants |
| Start Date | 2026-08-01 |
| Primary Completion | 2026-08-28 (estimated) |
| Study Completion | 2027-02-01 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-23 |